Allicin Release under Simulated Gastrointestinal Conditions from Garlic Powder Tablets Employed in Clinical Trials on Serum Cholesterol
The DOI matches its Crossref record.
Abstract
The failure of five recent clinical trials to show significant reduction in elevated serum cholesterol by a single brand of allicin-standardized garlic powder tablets is in contrast to many prior positive studies with the same brand. The hypocholesterolemic activity of garlic is mainly due to allicin, a compound that is produced by the acid-sensitive garlic enzyme, alliinase, only after tablet consumption. Therefore, the allicin-releasing ability of ten lots of these tablets--manufactured over the same years that the positive and negative clinical trials were conducted (1989-1997)--was determined under simulated gastrointestinal dissolution conditions, as defined by U.S. Pharmacopeia Method 724A. It was found that the older lots were more resistant to acid-disintegration (2.5 h vs. 1.3 h, P < 0.001) and that they released three times as much allicin (44% vs. 15 % of their potential, P < 0.001) as the newer lots. A second brand of tablets employed in a recent negative trial released no detectable amount of allicin, while a third set of tablets with high allicin release was used in a trial that gave positive effects. Hence, the persons involved in the recent negative clinical trials probably received considerably less allicin than did those in the older positive studies, possibly accounting for much of the discrepancy in the outcomes. In conclusion, clinical trials using garlic powder tablets to assess any effect of garlic that might be related to allicin, as most are, cannot be considered valid for garlic when the trial shows no effect, unless the expected allicin release from the tablets has at least been determined under standardized drug release conditions (USP 724A).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Health benefits of herbs and spices: the past, the present, the future
Tapsell, L. C., Hemphill, I., Cobiac, L., Sullivan, D. R., Fenech, M., Patch, C. S., Roodenrys, S., Keogh, J. B., Clifton, P. M., Williams, P. G., et al. (2006) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2006.tb00548.x · Cited by 988
Composition, stability, and bioavailability of garlic products used in a clinical trial
Lawson, L. D., & Gardner, C. D. (2005) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf050536+ · Cited by 227
Self-citationAllicin Bioavailability and Bioequivalence from Garlic Supplements and Garlic Foods
Lawson, L. D., & Hunsaker, S. M. (2018) · Nutrients · doi:10.3390/nu10070812 · Cited by 207
“Similarly, dissolution allicin release from nonenteric Kwai (Lichtwer Pharma, Berlin) tablets, the most commonly used garlic supplement in cardiovascular clinical trials [1,2], has also been found to be problematic: 44% for tablets made before 1993 and only 15% for tablets made from 1994–1997 [31].”
BackgroundSelf-citationEffect of garlic on serum lipids: an updated meta-analysis
Ried, K., Toben, C., & Fakler, P. (2013) · Nutrition Reviews · doi:10.1111/nure.12012 · Cited by 203
Sahebkar, A., Serban, C., Ursoniu, S., & Banach, M. (2016) · Nutrition · doi:10.1016/j.nut.2015.06.009 · Cited by 52
Metadata
- Authors
- Lawson*, L. D., Wang, Z. J., & Papadimitriou, D.
- Venue
- Planta Medica
- Publisher
- Georg Thieme Verlag KG
- Published
- 2001
- Volume
- 67
- Issue
- 1
- Pages
- 13-18
- ISSN
- 0032-0943 (ISSN-L)
- 1439-0221
- OpenAlex
- W2031061369
- Cited by
- 58
- References
- 0
- FWCI
- 3.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Allicin Release under Simulated Gastrointestinal Conditions from Garlic Powder Tablets Employed in Clinical Trials on Serum Cholesterol. https://app.cochat.ai/papers/10.1055/s-2001-10624
- The paper
- Lawson*, L. D., Wang, Z. J., & Papadimitriou, D. (2001). Allicin Release under Simulated Gastrointestinal Conditions from Garlic Powder Tablets Employed in Clinical Trials on Serum Cholesterol. Planta Medica. https://doi.org/10.1055/s-2001-10624
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.